A double-blind controlled comparison of the effects of chlorpromazine, barbiturate and a placebo in 142 chronic psychotic in-patients.
D000654:Amobarbital / Q000627:therapeutic use*; D001463:Barbiturates; D002746:Chlorpromazine / Q000627:therapeutic use*; D004311:Double-Blind Method; D006801:Humans; D011612:Psychosurgery; D011618:Psychotic Disorders / Q000628:therapy*
D001463:Barbiturates; D000654:Amobarbital; D002746:Chlorpromazine; C032232:barbituric acid
AMOBARBITAL/therapeutic use; CHLORPROMAZINE/therapeutic use; PSYCHOSES/therapy